RECRUITING

Impact of Yo-Yo Sleep on Cardiometabolic Health

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this clinical trial is to test the impact of repeated intermittent short sleep, with short sleep maintained 5 days per week followed by 2 days of prolonged sleep, compared to daily adequate sleep, on energy balance and cardiometabolic risk. A secondary goal of this research is to determine if maintaining a constant midpoint of sleep while undergoing intermittent short sleep, leads to better outcomes than intermittent short sleep with a 2-hour delay in sleep midpoint. The aims of this research will be tested in the context of a 3-group, parallel-arm, outpatient intervention of 4 weeks in duration, in young-to-middle-aged adults (aged 18-49 years).

Official Title

Impact of Yo-Yo Sleep on Cardiometabolic Health

Quick Facts

Study Start:2023-09-22
Study Completion:2028-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05880758

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 49 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * Aged 18 to 49 years
  2. * BMI 20-29.9 kg/m2
  3. * Habitually sleeping 7-9 hours/night without sleep aids or naps
  1. * Sleep disorders
  2. * Psychiatric disorders (including eating disorders) and seasonal affective disorder
  3. * Pregnancy (current/prior year)
  4. * Breastfeeding
  5. * Smokers (Any cigarette smoking or ex-smokers \<3years)
  6. * Diabetes
  7. * Elevated blood pressure, taking beta-blockers
  8. * Individuals taking anti-coagulants or anti-platelets
  9. * Recent weight change or participation in a weight loss program or have ever had bariatric surgery or other weight loss or gastrointestinal procedure.
  10. * Travel across time zones; shift work (non-traditional hours)

Contacts and Locations

Study Contact

Marie-Pierre St-Onge, PhD
CONTACT
212-305-9549
ms2554@cumc.columbia.edu
Greiby Mercedes
CONTACT
646-761-3455
gdm2130@cumc.columbia.edu

Principal Investigator

Marie-Pierre St-Onge, PhD
PRINCIPAL_INVESTIGATOR
Columbia University

Study Locations (Sites)

Columbia University Irving Medical Center
New York, New York, 10032
United States

Collaborators and Investigators

Sponsor: Columbia University

  • Marie-Pierre St-Onge, PhD, PRINCIPAL_INVESTIGATOR, Columbia University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-22
Study Completion Date2028-06

Study Record Updates

Study Start Date2023-09-22
Study Completion Date2028-06

Terms related to this study

Keywords Provided by Researchers

  • Sleep
  • Circadian Rhythms
  • Cardiometabolic Health

Additional Relevant MeSH Terms

  • Cardiometabolic Syndrome
  • Obesity